\-\ Texto\\:\\ \ \(0\)\
\-\ pt\\/ptt\\/inr\\ and\\ blood\\/platelet\\ counts\\ were\\ normal\\.\ \(0\)\
\-\ initial\\ non\\-contrast\\ head\\ ct\\ shows\\ parenchymal\\ hemorrhage\\ within\\ right\\ temporal\\ and\\ parietal\\ lobes\\,\\ with\\ subarachnoid\\ blood\\.\\ \\ right\\ transverse\\ sinus\\ appears\\ hyperdense\\,\\ as\\ do\\ visualized\\ vein\\ of\\ galen\\ and\\ straight\\ sinus\\.\\ \\ mrv\\ images\\ show\\ flow\\ void\\ at\\ right\\ transverse\\ sinus\\,\\ later\\ confirmed\\ with\\ angiography\\.\ \(0\)\
\-\ right\\ transverse\\ sinus\\ thrombosis\ \(1\)\
\-\ hemorrhage\\ in\\ a\\ young\\ adult\\ can\\ be\\ caused\\ by\\ avm\\,\\ hemorrhagic\\ primary\\ or\\ metastatic\\ neoplasm\\,\\ auto\\-immune\\ disease\\,\\ or\\ even\\ hypertension\\.\\ \\ the\\ findings\\ of\\ acute\\ occlusion\\ of\\ venous\\ sinus\\ is\\ more\\ narrow\\,\\ though\\ infiltrating\\ neoplasm\\ would\\ remain\\ in\\ differential\\ along\\ with\\ clot\\.\ \(0\)\
\-\ patient\\ with\\ acute\\ onset\\ of\\ headache\\ and\\ visual\\ disturbances\\ approximately\\ three\\ weeks\\ after\\ beginning\\ oral\\ contraceptives\\ to\\ help\\ control\\ dysfunctional\\ uterine\\ bleeding\\ secondary\\ to\\ fibroids\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ sinus\\:\\ 0\\.39069001500311673\ \(0\)\
\-\ transverse\\:\\ 0\\.2499507027152497\ \(0\)\
\-\ neoplasm\\:\\ 0\\.14763760935906173\ \(0\)\
\-\ dysfunctional\\:\\ 0\\.1466527833227097\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.14479890403424447\ \(0\)\
\-\ contraceptives\\:\\ 0\\.144420013544848\ \(0\)\
\-\ right\\:\\ 0\\.14340561212729008\ \(0\)\
\-\ counts\\:\\ 0\\.13473647967983993\ \(0\)\
\-\ galen\\:\\ 0\\.1292829962182924\ \(0\)\
\-\ mrv\\:\\ 0\\.12582679338234373\ \(0\)\
\-\ blood\\:\\ 0\\.12560197839659554\ \(0\)\
\-\ disturbances\\:\\ 0\\.12430945315048664\ \(0\)\
\-\ fibroids\\:\\ 0\\.1222394022513518\ \(0\)\
\-\ beginning\\:\\ 0\\.11922407121564917\ \(0\)\
\-\ void\\:\\ 0\\.11814054014293454\ \(0\)\
\-\ acute\\:\\ 0\\.11699437704229422\ \(0\)\
\-\ clot\\:\\ 0\\.11268705668138698\ \(0\)\
\-\ remain\\:\\ 0\\.10942935443381537\ \(0\)\
\-\ narrow\\:\\ 0\\.10608433451469242\ \(0\)\
\-\ infiltrating\\:\\ 0\\.10608433451469242\ \(0\)\
\-\ straight\\:\\ 0\\.10448141114434584\ \(0\)\
\-\ uterine\\:\\ 0\\.1009825611970982\ \(0\)\
\-\ angiography\\:\\ 0\\.09994642173150933\ \(0\)\
\-\ adult\\:\\ 0\\.09974582056880725\ \(0\)\
\-\ hyperdense\\:\\ 0\\.09954731998043025\ \(0\)\
\-\ occlusion\\:\\ 0\\.09935087642997799\ \(0\)\
\-\ help\\:\\ 0\\.09935087642997799\ \(0\)\
\-\ subarachnoid\\:\\ 0\\.09731455020256856\ \(0\)\
\-\ parenchymal\\:\\ 0\\.09713983345446839\ \(0\)\
\-\ avm\\:\\ 0\\.0956358759502953\ \(0\)\
\-\ though\\:\\ 0\\.09394631333874677\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.0937999293451126\ \(0\)\
\-\ control\\:\\ 0\\.09239509171632052\ \(0\)\
\-\ visual\\:\\ 0\\.09226016849210013\ \(0\)\
\-\ even\\:\\ 0\\.09096126101589094\ \(0\)\
\-\ lobes\\:\\ 0\\.09022259745180802\ \(0\)\
\-\ do\\:\\ 0\\.08962829696315934\ \(0\)\
\-\ and\\:\\ 0\\.08937953509674913\ \(0\)\
\-\ young\\:\\ 0\\.08916591713850756\ \(0\)\
\-\ bleeding\\:\\ 0\\.08838293604493265\ \(0\)\
\-\ thrombosis\\:\\ 0\\.08816504131285996\ \(0\)\
\-\ parietal\\:\\ 0\\.0873176764271044\ \(0\)\
\-\ caused\\:\\ 0\\.08670611910251018\ \(0\)\
\-\ oral\\:\\ 0\\.08660608386785053\ \(0\)\
\-\ with\\:\\ 0\\.08469715618094249\ \(0\)\
\-\ of\\:\\ 0\\.08464657986964054\ \(0\)\
\-\ visualized\\:\\ 0\\.08443994555745526\ \(0\)\
\-\ temporal\\:\\ 0\\.08306691970484337\ \(0\)\
\-\ hypertension\\:\\ 0\\.08273865811751054\ \(0\)\
\-\ confirmed\\:\\ 0\\.07973529540910555\ \(0\)\
\-\ appears\\:\\ 0\\.07918777336454448\ \(0\)\
\-\ vein\\:\\ 0\\.07751024255908381\ \(0\)\
\-\ later\\:\\ 0\\.077387147107218\ \(0\)\
\-\ venous\\:\\ 0\\.07720398980820718\ \(0\)\
\-\ would\\:\\ 0\\.0765471588652073\ \(0\)\
\-\ or\\:\\ 0\\.07523685210963346\ \(0\)\
\-\ headache\\:\\ 0\\.07454401022130523\ \(0\)\
\-\ three\\:\\ 0\\.07258901992663591\ \(0\)\
\-\ initial\\:\\ 0\\.07254144993184349\ \(0\)\
\-\ along\\:\\ 0\\.07244666656949253\ \(0\)\
\-\ flow\\:\\ 0\\.0720259102168845\ \(0\)\
\-\ differential\\:\\ 0\\.07026122923314315\ \(0\)\
\-\ onset\\:\\ 0\\.06943689792613529\ \(0\)\
\-\ approximately\\:\\ 0\\.06899834427116602\ \(0\)\
\-\ show\\:\\ 0\\.06864692391530539\ \(0\)\
\-\ primary\\:\\ 0\\.06649168648673845\ \(0\)\
\-\ weeks\\:\\ 0\\.06480774577159562\ \(0\)\
\-\ head\\:\\ 0\\.06449440586113957\ \(0\)\
\-\ secondary\\:\\ 0\\.06409465669512633\ \(0\)\
\-\ shows\\:\\ 0\\.06346620246864054\ \(0\)\
\-\ more\\:\\ 0\\.059377972923492055\ \(0\)\
\-\ metastatic\\:\\ 0\\.059306929868535786\ \(0\)\
\-\ can\\:\\ 0\\.056746101394551274\ \(0\)\
\-\ were\\:\\ 0\\.05574074211499228\ \(0\)\
\-\ to\\:\\ 0\\.054067341141955626\ \(0\)\
\-\ in\\:\\ 0\\.05380122180083223\ \(0\)\
\-\ findings\\:\\ 0\\.05336922234549793\ \(0\)\
\-\ after\\:\\ 0\\.05245831919496228\ \(0\)\
\-\ images\\:\\ 0\\.05001988281077533\ \(0\)\
\-\ within\\:\\ 0\\.049803891492205175\ \(0\)\
\-\ by\\:\\ 0\\.045920618435321206\ \(0\)\
\-\ disease\\:\\ 0\\.04539145475841406\ \(0\)\
\-\ normal\\:\\ 0\\.044151012607237035\ \(0\)\
\-\ be\\:\\ 0\\.04386626227944004\ \(0\)\
\-\ as\\:\\ 0\\.043441880946000364\ \(0\)\
\-\ ct\\:\\ 0\\.04116821226774962\ \(0\)\
\-\ at\\:\\ 0\\.04084415936860661\ \(0\)\
\-\ patient\\:\\ 0\\.0351710600092109\ \(0\)\
\-\ is\\:\\ 0\\.029613650091692718\ \(0\)\
\-\ the\\:\\ 0\\.021576956874613386\ \(0\)\
